Biofarm will invest 47 million lei in upgrading equipment and developing a new R&D center by 2025.
Raluca Ioana Draghici
Economy
www.shutterstock.com
Always see our news on Google
Biofarm, a leading Romanian drug manufacturer, plans to invest 47 million lei in upgrading its production plant on Logofătul Tăutu Street and developing a new research and development center. The project aims to modernize equipment in order to improve the efficiency of manufacturing processes and better respond to market demands. CEO Cătălin Vicol emphasizes that this initiative is part of Biofarm's strategy to increase its presence on international markets.
Sources
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare. Bugetul de investiţii al Biofarm în 2025 este de 47 mil. lei (aproape 10 mil. euro), în creştere faţă de anul anterior, cand a fost de 31 mil. lei
Producătorul de medicamente Biofarm are în plan modernizarea primei fabrici din Bucureşti şi un centru nou de cercetare
Latest News
20:20
Cseke Attila states that UDMR supports the formation of a "large coalition" to ensure a government with full powers and to prevent the "extreme" from accessing governance.
20:06
The Romanian Army will receive equipment produced in the country, announces Minister Radu Miruță.
19:49
A radio station in Great Britain mistakenly announced the death of King Charles III. The media authority classified the information as a "significant inaccuracy."
19:34
Poland and the Baltic states warn that Russia may be preparing attacks under a "false flag" using Ukrainian drones.
19:26
Fire at an ammunition factory in Bulgaria, after a tanker truck was engulfed in flames. 300 workers were evacuated, and authorities have not reported any casualties.
See more news
NEWS ON THE SAME TOPICS
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
